Free Trial

Genesis Healthcare (GEN) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

GEN vs. NTES, PLTR, SNOW, ADSK, TEAM, SQ, DDOG, EA, HUBS, and MSTR

Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include NetEase (NTES), Palantir Technologies (PLTR), Snowflake (SNOW), Autodesk (ADSK), Atlassian (TEAM), Block (SQ), Datadog (DDOG), Electronic Arts (EA), HubSpot (HUBS), and MicroStrategy (MSTR). These companies are all part of the "prepackaged software" industry.

Genesis Healthcare vs.

Genesis Healthcare (NYSE:GEN) and NetEase (NASDAQ:NTES) are both large-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Genesis Healthcare has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, NetEase has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500.

82.1% of Genesis Healthcare shares are held by institutional investors. Comparatively, 11.1% of NetEase shares are held by institutional investors. 3.3% of Genesis Healthcare shares are held by insiders. Comparatively, 54.7% of NetEase shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

NetEase has higher revenue and earnings than Genesis Healthcare. NetEase is trading at a lower price-to-earnings ratio than Genesis Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genesis Healthcare$2.80B5.65$836M$0.9027.47
NetEase$14.57B4.14$4.14B$6.4514.56

In the previous week, NetEase had 2 more articles in the media than Genesis Healthcare. MarketBeat recorded 3 mentions for NetEase and 1 mentions for Genesis Healthcare. NetEase's average media sentiment score of 1.41 beat Genesis Healthcare's score of 0.00 indicating that NetEase is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Genesis Healthcare
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NetEase
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Genesis Healthcare currently has a consensus price target of $26.20, indicating a potential upside of 5.99%. NetEase has a consensus price target of $125.71, indicating a potential upside of 33.88%. Given NetEase's stronger consensus rating and higher probable upside, analysts plainly believe NetEase is more favorable than Genesis Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genesis Healthcare
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
NetEase
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

NetEase has a net margin of 28.75% compared to Genesis Healthcare's net margin of 17.83%. Genesis Healthcare's return on equity of 155.48% beat NetEase's return on equity.

Company Net Margins Return on Equity Return on Assets
Genesis Healthcare17.83% 155.48% 9.12%
NetEase 28.75%24.19%16.80%

Genesis Healthcare pays an annual dividend of $0.50 per share and has a dividend yield of 2.0%. NetEase pays an annual dividend of $1.97 per share and has a dividend yield of 2.1%. Genesis Healthcare pays out 55.6% of its earnings in the form of a dividend. NetEase pays out 30.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. NetEase is clearly the better dividend stock, given its higher yield and lower payout ratio.

NetEase received 197 more outperform votes than Genesis Healthcare when rated by MarketBeat users. Likewise, 69.02% of users gave NetEase an outperform vote while only 65.69% of users gave Genesis Healthcare an outperform vote.

CompanyUnderperformOutperform
Genesis HealthcareOutperform Votes
469
65.69%
Underperform Votes
245
34.31%
NetEaseOutperform Votes
666
69.02%
Underperform Votes
299
30.98%

Summary

NetEase beats Genesis Healthcare on 15 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEN vs. The Competition

MetricGenesis HealthcarePrepackaged software IndustryBusiness SectorNYSE Exchange
Market Cap$15.80B$21.14B$6.22B$17.62B
Dividend Yield3.05%2.05%2.99%3.57%
P/E Ratio27.4747.1028.2521.91
Price / Sales5.657.2780.6514.02
Price / Cash8.4267.2026.6719.34
Price / Book-154.509.654.624.80
Net Income$836M$359.45M$117.42M$973.40M

Genesis Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NTES
NetEase
4.9086 of 5 stars
$88.68
+0.4%
$125.71
+41.8%
+1.7%$56.71B$14.57B13.7529,128Positive News
PLTR
Palantir Technologies
1.7007 of 5 stars
$22.10
+3.7%
$20.65
-6.5%
+55.3%$47.48B$2.23B184.183,735Gap Down
SNOW
Snowflake
4.7788 of 5 stars
$137.00
+0.1%
$200.64
+46.5%
-23.1%$45.76B$2.81B-48.937,004
ADSK
Autodesk
4.5885 of 5 stars
$212.00
+0.6%
$269.05
+26.9%
+7.3%$45.43B$5.50B50.3613,700Upcoming Earnings
TEAM
Atlassian
4.3808 of 5 stars
$157.94
-0.9%
$223.22
+41.3%
-5.0%$41.50B$3.53B-250.706,433Analyst Upgrade
SQ
Block
4.6395 of 5 stars
$64.24
-0.1%
$87.59
+36.4%
+0.2%$39.68B$21.92B83.4312,985
DDOG
Datadog
4.8744 of 5 stars
$108.84
-0.5%
$137.50
+26.3%
+14.5%$36.57B$2.13B340.135,200Insider Selling
EA
Electronic Arts
4.3655 of 5 stars
$136.50
+2.6%
$147.00
+7.7%
+8.6%$35.43B$7.56B29.1713,700
HUBS
HubSpot
3.3641 of 5 stars
$608.92
+2.0%
$640.04
+5.1%
+15.4%$30.43B$2.17B-229.787,663Positive News
MSTR
MicroStrategy
2.8905 of 5 stars
$1,638.77
+0.7%
$1,793.00
+9.4%
+465.4%$28.87B$496.26M-244.591,934

Related Companies and Tools

This page (NYSE:GEN) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners